Marinus Pharmaceuticals Inc (MRNS)
0.3351
+0.01
(+2.20%)
USD |
NASDAQ |
Nov 04, 16:00
0.3227
-0.01
(-3.70%)
After-Hours: 20:00
Marinus Pharmaceuticals Gross Profit Margin (Quarterly): 90.88% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 90.88% |
| March 31, 2024 | 90.16% |
| December 31, 2023 | 87.66% |
| September 30, 2023 | 93.80% |
| June 30, 2023 | 93.65% |
| March 31, 2023 | 98.02% |
| Date | Value |
|---|---|
| December 31, 2022 | 95.92% |
| September 30, 2022 | 97.95% |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | 85.39% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
85.39%
Minimum
Sep 2021
98.02%
Maximum
Mar 2023
92.60%
Average
93.65%
Median
Jun 2023
Gross Profit Margin (Quarterly) Benchmarks
| Chimerix Inc | -- |
| Cellectar Biosciences Inc | -- |
| Ocular Therapeutix Inc | 90.82% |
| Viking Therapeutics Inc | -- |
| Jaguar Health Inc | 84.31% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -1.15K% |
| Return on Assets | -93.58% |
| Return on Invested Capital | -180.9% |
| Profit Margin (Quarterly) | -444.7% |
| Operating Margin (Quarterly) | -375.9% |
| Return on Net Operating Assets | -1.17K% |